Literature DB >> 11746827

Sterol-independent regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in tumor cells.

P Hentosh1, S H Yuh, C E Elson, D M Peffley.   

Abstract

Elevated 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase expression supports synthesis of prenyl pyrophosphate intermediates required for tumor growth. In this study, the copy number of HMG-CoA reductase mRNA was determined in solid tumor and leukemic cell lines using competitive reverse transcriptase-polymerase chain reaction. Reductase mRNA was increased about eight-fold in Caco2 human colon adenocarcinoma cells compared with that in CCD18 normal colon cells. We also found a 50-fold enhancement of reductase mRNA in stimulated human lymphocytes compared with unstimulated cells. In CEM human leukemia cells, reductase mRNA was increased 8.6 times compared with that in stimulated lymphocytes. Greater low density lipoprotein receptor mRNA was also observed in tumor cells compared with normal counterparts. We hypothesized that elevated reductase mRNA was due to attenuation of sterol-mediated control of tumor reductase promoter activity. We first compared the methylation status of CpG dinucleotides in the promoters of reductase and p16 tumor suppressor genes from solid tumor, leukemic, and normal cells. As reported for other tumor cells the p16 promoter region was hypermethylated in Caco2 and CEM cells but was hypomethylated in corresponding normal cells. However, reductase promoter sequences in both normal and tumor cells were hypomethylated, demonstrating that methylation is not involved in sterol-independent reductase regulation. We addressed altered transcription factor binding to the tumor cell reductase promoter by transiently transfecting Caco2 and CCD18 with a plasmid vector containing a hamster HMG-CoA reductase promoter fused to the luciferase gene. We found that increased reductase mRNA was partially due to an approximately three-fold higher reductase promoter activity in Caco2 than in CCD18, measured by luciferase reporter assays. Thus, differential binding of transcription factor or factors on the tumor cell reductase promoter attenuates normal sterol-mediated regulation of reductase activity. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746827     DOI: 10.1002/mc.1074

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  12 in total

1.  Do statins decrease the risk of colorectal cancer?

Authors:  Melinda Hillmer; David N Juurlink
Journal:  CMAJ       Date:  2005-09-27       Impact factor: 8.262

2.  Can statins reduce risk of lung cancer, especially among elderly people? A meta-analysis.

Authors:  Zhantao Deng; Shu Zhang; Long Yi; Shilin Chen
Journal:  Chin J Cancer Res       Date:  2013-12       Impact factor: 5.087

Review 3.  The effect of statins on cancer cells--review.

Authors:  Lucyna Matusewicz; Justyna Meissner; Monika Toporkiewicz; Aleksander F Sikorski
Journal:  Tumour Biol       Date:  2015-05-23

4.  Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts.

Authors:  Liyan Zhuang; Jayoung Kim; Rosalyn M Adam; Keith R Solomon; Michael R Freeman
Journal:  J Clin Invest       Date:  2005-03-17       Impact factor: 14.808

5.  Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.

Authors:  Svenja Nölting; Edwin Garcia; Ghassan Alusi; Alessio Giubellino; Karel Pacak; Márta Korbonits; Ashley B Grossman
Journal:  J Mol Endocrinol       Date:  2012-07-25       Impact factor: 5.098

6.  Novel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statins.

Authors:  Jean-Pierre H Perchellet; Elisabeth M Perchellet; Kyle R Crow; Keith R Buszek; Neil Brown; Sampathkumar Ellappan; Ge Gao; Diheng Luo; Machiko Minatoya; Gerald H Lushington
Journal:  Int J Mol Med       Date:  2009-11       Impact factor: 4.101

7.  Statins and the risk of colorectal carcinoma: a nested case-control study in veterans with diabetes.

Authors:  Christine Hachem; Robert Morgan; Michael Johnson; Mark Kuebeler; Hashem El-Serag
Journal:  Am J Gastroenterol       Date:  2009-04-07       Impact factor: 10.864

8.  Anticancer activity of the cholesterol exporter ABCA1 gene.

Authors:  Bradley Smith; Hartmut Land
Journal:  Cell Rep       Date:  2012-09-13       Impact factor: 9.423

9.  Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells.

Authors:  Mee Young Hong; Navindra P Seeram; Yanjun Zhang; David Heber
Journal:  J Nutr Biochem       Date:  2007-09-14       Impact factor: 6.048

10.  Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases.

Authors:  Y Zhu; P J Casey; A P Kumar; S Pervaiz
Journal:  Cell Death Dis       Date:  2013-04-04       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.